149 related articles for article (PubMed ID: 14691170)
1. Anti-TNFalpha therapy modulates the phenotype of peripheral blood CD4+ T cells in patients with posterior segment intraocular inflammation.
Greiner K; Murphy CC; Willermain F; Duncan L; Plskova J; Hale G; Isaacs JD; Forrester JV; Dick AD
Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):170-6. PubMed ID: 14691170
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha: a key factor in autoimmune disease?
Plskova J; Greiner K; Muckersie E; Duncan L; Forrester JV
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3946-50. PubMed ID: 16936109
[TBL] [Abstract][Full Text] [Related]
3. Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitis.
Murphy CC; Greiner K; Plskova J; Duncan L; Frost A; Isaacs JD; Rebello P; Waldmann H; Hale G; Forrester JV; Dick AD
Arch Ophthalmol; 2004 Jun; 122(6):845-51. PubMed ID: 15197059
[TBL] [Abstract][Full Text] [Related]
4. Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis.
Dick AD; Duncan L; Hale G; Waldmann H; Isaacs J
J Autoimmun; 1998 Jun; 11(3):255-64. PubMed ID: 9693974
[TBL] [Abstract][Full Text] [Related]
5. Expression of Th1 markers by lung accumulated T cells in pulmonary sarcoidosis.
Katchar K; Eklund A; Grunewald J
J Intern Med; 2003 Dec; 254(6):564-71. PubMed ID: 14641797
[TBL] [Abstract][Full Text] [Related]
6. Systemic CD4(+) T cell phenotype and activation status in intermediate uveitis.
Murphy CC; Duncan L; Forrester JV; Dick AD
Br J Ophthalmol; 2004 Mar; 88(3):412-6. PubMed ID: 14977779
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina.
Dick AD; McMenamin PG; Körner H; Scallon BJ; Ghrayeb J; Forrester JV; Sedgwick JD
Eur J Immunol; 1996 May; 26(5):1018-25. PubMed ID: 8647162
[TBL] [Abstract][Full Text] [Related]
8. Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-alpha inhibitors.
Aeberli D; Seitz M; Jüni P; Villiger PM
Rheumatology (Oxford); 2005 Feb; 44(2):172-5. PubMed ID: 15509629
[TBL] [Abstract][Full Text] [Related]
9. CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-γ) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency.
Kutukculer N; Azarsiz E; Aksu G; Karaca NE
Int J Immunopathol Pharmacol; 2016 Jun; 29(2):241-51. PubMed ID: 26684629
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine vs tacrolimus therapy for posterior and intermediate uveitis.
Murphy CC; Greiner K; Plskova J; Duncan L; Frost NA; Forrester JV; Dick AD
Arch Ophthalmol; 2005 May; 123(5):634-41. PubMed ID: 15883282
[TBL] [Abstract][Full Text] [Related]
11. Riding on a carousel with IFN-alpha and TNF-alpha.
Zierhut M
Ocul Immunol Inflamm; 1998 Dec; 6(4):209-10. PubMed ID: 9924916
[No Abstract] [Full Text] [Related]
12. Selective recruitment of CXCR3+ and CCR5+ CCR4+ T cells into synovial tissue in patients with rheumatoid arthritis.
Norii M; Yamamura M; Iwahashi M; Ueno A; Yamana J; Makino H
Acta Med Okayama; 2006 Jun; 60(3):149-57. PubMed ID: 16838043
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of the chemokine receptors by the Th1- and Th2-type effector populations within circulating CD4+ T cells.
Yamamoto J; Adachi Y; Onoue Y; Adachi YS; Okabe Y; Itazawa T; Toyoda M; Seki T; Morohashi M; Matsushima K; Miyawaki T
J Leukoc Biol; 2000 Oct; 68(4):568-74. PubMed ID: 11037980
[TBL] [Abstract][Full Text] [Related]
14. Type I interferons as immunoregulatory molecules; implications for therapy in experimental autoimmune uveoretinitis.
Mizuguchi J; Takeuchi M; Usui M
Arch Immunol Ther Exp (Warsz); 2002; 50(4):243-54. PubMed ID: 12371620
[TBL] [Abstract][Full Text] [Related]
15. Oral administration of retinoic acid receptor-alpha/beta-specific ligand Am80 suppresses experimental autoimmune uveoretinitis.
Keino H; Watanabe T; Sato Y; Okada AA
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1548-56. PubMed ID: 20861477
[TBL] [Abstract][Full Text] [Related]
16. Chemokine receptor CCR4 on CD4+ T cells in juvenile rheumatoid arthritis synovial fluid defines a subset of cells with increased IL-4:IFN-gamma mRNA ratios.
Thompson SD; Luyrink LK; Graham TB; Tsoras M; Ryan M; Passo MH; Glass DN
J Immunol; 2001 Jun; 166(11):6899-906. PubMed ID: 11359851
[TBL] [Abstract][Full Text] [Related]
17. [Translational research with experimental autoimmune uveoretinitis (EAU)].
Usui M
Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):137-58; discussion 159. PubMed ID: 17402560
[TBL] [Abstract][Full Text] [Related]
18. C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential.
Andrew DP; Ruffing N; Kim CH; Miao W; Heath H; Li Y; Murphy K; Campbell JJ; Butcher EC; Wu L
J Immunol; 2001 Jan; 166(1):103-11. PubMed ID: 11123282
[TBL] [Abstract][Full Text] [Related]
19. Neutralizing tumor necrosis factor-alpha activity suppresses activation of infiltrating macrophages in experimental autoimmune uveoretinitis.
Robertson M; Liversidge J; Forrester JV; Dick AD
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3034-41. PubMed ID: 12824249
[TBL] [Abstract][Full Text] [Related]
20. Circulating lymphocyte subsets linked to intracellular cytokine profiles in normal humans.
Matsui M; Araya S; Wang HY; Onai N; Matsushima K; Saida T
Clin Exp Immunol; 2003 Nov; 134(2):225-31. PubMed ID: 14616781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
